https://gastroenterology.acponline.org/archives/2019/08/23/6.htm. Based on data from an ongoing safety trial, the FDA has approved a new warning about an increased risk of blood ... The FDA has approved new warnings for the 10-mg twice-daily dose of
One lot of senna syrup (8.8 mg in 5-mL unit-dose cups) was recalled by Lohxa LLC due to potential microbial contamination, the FDA announced on Jan. ... Recalled products were distributed to wholesaler AvKare, which may have further distributed them to
Eleven lots of ranitidine tablets, USP (150 mg) were recalled by American Health Packaging due to the potential to contain excess amounts of N-nitrosodimethylamine (NDMA), a probable carcinogen, the FDA
One lot of pantoprazole sodium for injection (40 mg per vial) was recalled from hospitals nationwide, the FDA announced on Dec.
Liva Global Inc. recalled two lots of liquid probiotics due to the possibility of contamination by Pseudomonas aeruginosa, the FDA announced on Dec.
The FDA authorized marketing of the first fully disposable duodenoscope on Dec. ... each year, and the FDA has encouraged innovative ways to improve their safety and effectiveness, particularly with regard to cleaning and disinfecting, the agency said in
The FDA has approved the first treatment for patients with eosinophilic esophagitis, the agency announced on May 20.
On June 5, the FDA approved the first generic form of mesalamine delayed-release oral tablets USP (1.2 g).
The FDA announced on May 26 that it is restricting the use of obeticholic acid (Ocaliva) in patients with primary biliary cholangitis (PBC) and advanced cirrhosis. ... Based on the original clinical trials, the FDA believes the benefits of the drug
cap. On Feb. 7, the FDA cleared the updated design and labeling for the Pentax Medical Duodenoscope Model ED-3490TK. ... The FDA continues to monitor the association between reprocessed endoscopes and transmission of infectious agents.